Article
Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.
Answering Your Questions About Cosmeceutical Peptides
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Hair-Raising Challenges
Tailoring Aesthetic Treatments for Patients With Skin of Color